Coronavirus Vaccine Trial Paused
- All
- News
- Videos
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
AstraZeneca UK Vaccine Trial On Children Paused As Clot Link Probed
A British trial of the AstraZeneca coronavirus vaccine on children has been paused while regulators assess its possible link to blood clots, Oxford University, which helped develop the jab, said Tuesday.
-
Johnson & Johnson Pauses Covid Vaccine Trial As Participant Falls Ill
Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.
-
Johnson & Johnson Pauses Coronavirus Vaccine Trial After Participant Becomes Ill
Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.
-
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
-
Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment
New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.
-
AstraZeneca Vaccine Trial Pause A "Wake-Up Call", Says WHO
AstraZeneca's pause of an experimental vaccine for the coronavirus after the illness of a participant is a "wake-up call" but should not discourage researchers, the World Health Organization's (WHO) chief scientist said on Thursday.
-
Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice
Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phase 3 trials that were to begin in India next week. The vaccine trial was stopped across four nations as a precautionary measure after one of the recipients in...
-
Adar Poonawalla's Serum Institute Gets Notice on Pausing Vaccine Trial
The Serum Institute of India, which is manufacturing the Oxford University's Covishield vaccine and will hold the phase 3 clinical trials in India from next week, has been issued a showcause notice by the country's drug controller DCGI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the...
-
Vaccine Safety Top Priority, Says WHO As AstraZeneca Pauses Study
Safety of a prospective COVID-19 vaccine comes "first and foremost", the World Health Organization's chief scientist said on Wednesday, as a trial of a leading candidate from AstraZeneca was paused due to concerns over side effects.
-
Oxford Trials Pause Could Disrupt Closely-Watched Race For Vaccine
AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company's studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19.
-
Astrazeneca Pharma India Shares Dive Nearly 7% As Vaccine Trials Paused
The parent company AstraZeneca "voluntarily paused" a randomized clinical trial of its coronavirus vaccine asa volunteer developed an unexplained illness.
-
Trials Of Oxford Vaccine "Paused" After Unexpected Illness In Volunteer
Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.
-
US Health Regulator Lifts Hold On Covaxin's Clinical Trials
The US Food and Drug Administration which has put on hold phase 2/ 3 clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin, in USA, has lifted pause, according to a statement issued by Ocugen Inc, Bharat Biotech's partner for jab in US, Canada
-
AstraZeneca UK Vaccine Trial On Children Paused As Clot Link Probed
A British trial of the AstraZeneca coronavirus vaccine on children has been paused while regulators assess its possible link to blood clots, Oxford University, which helped develop the jab, said Tuesday.
-
Johnson & Johnson Pauses Covid Vaccine Trial As Participant Falls Ill
Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.
-
Johnson & Johnson Pauses Coronavirus Vaccine Trial After Participant Becomes Ill
Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.
-
Oxford Vaccine Trials Resume In UK, Were Paused Over Volunteer's Illness
Pharma giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.
-
Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment
New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.
-
AstraZeneca Vaccine Trial Pause A "Wake-Up Call", Says WHO
AstraZeneca's pause of an experimental vaccine for the coronavirus after the illness of a participant is a "wake-up call" but should not discourage researchers, the World Health Organization's (WHO) chief scientist said on Thursday.
-
Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice
Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phase 3 trials that were to begin in India next week. The vaccine trial was stopped across four nations as a precautionary measure after one of the recipients in...
-
Adar Poonawalla's Serum Institute Gets Notice on Pausing Vaccine Trial
The Serum Institute of India, which is manufacturing the Oxford University's Covishield vaccine and will hold the phase 3 clinical trials in India from next week, has been issued a showcause notice by the country's drug controller DCGI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the...
-
Vaccine Safety Top Priority, Says WHO As AstraZeneca Pauses Study
Safety of a prospective COVID-19 vaccine comes "first and foremost", the World Health Organization's chief scientist said on Wednesday, as a trial of a leading candidate from AstraZeneca was paused due to concerns over side effects.
-
Oxford Trials Pause Could Disrupt Closely-Watched Race For Vaccine
AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in one of the company's studies got sick, a potential adverse reaction that could delay or derail efforts to speed an immunization against Covid-19.
-
Astrazeneca Pharma India Shares Dive Nearly 7% As Vaccine Trials Paused
The parent company AstraZeneca "voluntarily paused" a randomized clinical trial of its coronavirus vaccine asa volunteer developed an unexplained illness.
-
Trials Of Oxford Vaccine "Paused" After Unexpected Illness In Volunteer
Pharmaceutical company AstraZeneca said Tuesday it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness.
